rs7291467

Orientation

plus

Stabilized

plus

Make rs7291467(A;A)

Make rs7291467(A;G)

Make rs7291467(G;G)

Reference

GRCh38 38.1/141

Chromosome

22

Position

37576621

Gene

LGALS2

is a	snp
is	mentioned by
dbSNP	rs7291467
dbSNP (classic)	rs7291467
ClinGen	rs7291467
ebi	rs7291467
HLI	rs7291467
Exac	rs7291467
Gnomad	rs7291467
Varsome	rs7291467
LitVar	rs7291467
Map	rs7291467
PheGenI	rs7291467
Biobank	rs7291467
1000 genomes	rs7291467
hgdp	rs7291467
ensembl	rs7291467
geneview	rs7291467
scholar	rs7291467
google	rs7291467
pharmgkb	rs7291467
gwascentral	rs7291467
openSNP	rs7291467
23andMe	rs7291467
SNPshot	rs7291467
SNPdbe	rs7291467
MSV3d	rs7291467
GWAS Ctlg	rs7291467

GMAF

0.4389

Max Magnitude

0

?	(A;A) (A;G) (G;G)	28

[PMID 20500087] Age-Related Susceptibility to Severe Malaria Associated with Galectin-2 in Highland Papuans

[PMID 22310064] Polymorphisms of LTA, LGALS2, and PSMA6 genes and coronary atherosclerosis: a pathological study of 1503 consecutive autopsy cases

[PMID 16468038] Genotype of galectin 2 (LGALS2) is associated with insulin-glucose profile in the British Women's Heart and Health Study.

[PMID 17098239] LGALS2 functional variant rs7291467 is not associated with susceptibility to myocardial infarction in Caucasians.

[PMID 17517687] Association of variants in the BAT1-NFKBIL1-LTA genomic region with protection against myocardial infarction in Europeans.

[PMID 17767904] Genetic and genomic insights into the molecular basis of atherosclerosis.

[PMID 18506375] Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome.

[PMID 21831908] Galectin-2 expression is dependent on the rs7291467 polymorphism and acts as an inhibitor of arteriogenesis.

Coronary Heart Disease